Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지

Effects of Recombinant Human Erythropoietin Treatment in Male Cynomolgus Monkeys (Macaca fascicularis) (I): Hematological and Histopathological Changes

  • Published : 2005.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. 김달현, 임동문, 조효진, 박관하, 하병집, 김현수 (1994): 새로운 유전 공학적 방법에 의해 생산한 Erythropoietin의 rat에서의 4주 아급성 독성. Korean J. Toxicol., 10, 243-254
  2. 남정석, 제정환, 이석만, 양재만, 강병철, 이학모, 박재학, 송동호, 유선희, 이영순 (1997): 랫드에서 EPO(erythropoietin)의 4주간 정맥 반복투여 독성시험 Korean J. Toxicol.,13, 131-138
  3. 정광희 (2004): 유전자재조합 의약품 연구동향. 보건산업기술동향, 가을호, 30-38
  4. 제정환, 남정석, 이석만, 강병철, 이학모, 박재학, 송동호, 유선희, 이영순(1997): 토끼에서 EPO(erythropoietin)의 4주간 정맥 반복투여 독성시험에 관한 연구. Korean J. Toxicol., 13, 139-147
  5. 조명행, 성하정, 곽승준, 천선아, 임소영, 김원배, 김병문, 안병옥, 이병무(1998): 비글견에서 인체 재조합 적혈구 조혈인자, rHu-EPO의 급성독성에 관한 연구. J. Appl. Pharmacol., 6, 317-327
  6. Cazzola, M. (2003): Erythropoietin therapy: need for rationality and active surveillance. Haematalagica, 88, 601-605
  7. Ekblom, B., Goldbarg, A.N. and Gullbring, B. (1972): Response to exercise after blood loss and reinfusion. J. Appl. Physiol., 33, 175-180 https://doi.org/10.1152/jappl.1972.33.2.175
  8. Eschbach, J.W. and Adamson, J.W. (1989): Guidelines for recombinant human erythropoietin therapy. Am. J. Kindey Dis., 14, 2-8 https://doi.org/10.1016/S0272-6386(89)80086-1
  9. Fisher, J.W (1993): Recent advances in erythropoietin research. Prog. Drug Res., 41, 293-311
  10. Furuno, T., Komastu, H., Noguchi, N., Noguchi, G., Suzuki, S., Kataoka, S., Usami, M., Saito, K. and Tatsumi, T. (1990): Thirteen-week intravenous toxicity study of EPOCH in rhesus monkeys (Macaca mulatta). Rinshauigaku, 6, 271-289
  11. Jacobs, K., Shoemaker, C., Rudersdorf, R, Neil, S.D., Kaufman, RJ., Mufson, A., Seehra, J., Jones, S.S., Hewick, R, Fretch, E.F., Kawakita. M., Shimizu, T. and Miyake, T. (1985): Isolation and characterization of genomic and eDNA clones of human erythropoietin. Nature, 313, 806-810 https://doi.org/10.1038/313806a0
  12. Jelkmann, W. (2000): Use of recombinant human erythropoietin as an anti-anemic and performance enhancing drug. Curr. Pharmaceut. Biotechnol., 1, 11-31 https://doi.org/10.2174/1389201003379068
  13. Gebbia, V., Palmeri, S., Valenza, R, Rausam, L. and Citarrella, P. (1991): The in vivo effects of recombinant human erythropoietin on cisdiamminodichloroplatinum-induced anemia in Golden Syrian hamsters. In Vivo, 5, 149-152
  14. Kim, C.-Y., Han, S.-C., Heo, J.-D., Lee, H.-S., Ha, C.-S., Kang, B.-H., Kwon, M.-S. and Han, S.-S. (2004): Effect of transportation on hematological and serum biochemical values in cynomolgus monkeys. Korean J. Lab. Ani. Sci., 20, 328-332
  15. Koury, S.T, Bondurant, M.C. and Koury, M.J. (1988): Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood, 71, 524-527
  16. Lin, F.K., Suggs, S., Kin, C.H., Browne, J.K., Smalling, R., Egrie, J.C., Cjen, K.K., Fox, G.M., Martin, F., Stabinsky, Z., Badrawi, S.M., Lai, P.H. and Goldwasser, E. (1985): Cloning and expression of the human erythropoietin gene. Proc. Natl. A cad. Sci. USA, 82, 7580-7584 https://doi.org/10.1073/pnas.82.22.7580
  17. Ng, T., Marx, G., Littlewood, T. and Macdougall, I. (2003): Recombinant erythropoietin in clinical practice. Postgrad Med. J, 79, 367-376 https://doi.org/10.1136/pmj.79.933.367
  18. Shriver, Z., Raguram, S. and Sasisekharan, R. (2004) Glycomics: a pathway to a class of new and improved therapeutics. Nat. Rev. Drug Discov., 3, 863-873 https://doi.org/10.1038/nrd1521
  19. Vaziri, N.D., Zhou, X.J. and Liao, S.Y. (1994): Erythropoietin enhances recovery from cisplatin-induced acute renal failure. Am. J. Physiol., 266, F360-F366 https://doi.org/10.1152/ajpcell.1994.266.2.C360
  20. Wiwanitkit, V. (2004): Plateletcrit, mean platelet volume, platelet distribution width: its expected values and correlation with parallel red blood cell parameters. Clin. Appl. Thrombo. Hemost., 10, 175-178 https://doi.org/10.1177/107602960401000208